Clinical study on Bushen Huoxue Decoction in the treatment of peripheral neuropathy of multiple myeloma

Phase 1

• Conditions: multiple myeloma

• Registration Number: ITMCTR2000003809
• Lead Sponsor: Shanghai municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Multiple myeloma peripheral neuropathy was diagnosed;
2) Aged between 25 and 85 years old;
3) Conscious and willing to accept the trial treatment.

Exclusion Criteria

1) Those who do not meet the inclusion criteria;
2) Those who are allergic to the test drug;
3) Patients with important organ dysfunction and mental disorders;
4) Participants in other clinical drug trials;
5) Those who suffer from mental illness or mental disorder and cannot be controlled.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurological sign score;nerve conduction velocity;Neurological symptom score;M protein;Curative effect of TCM Syndrome;